BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keutgen XM, Hammel P, Choyke PL, Libutti SK, Jonasch E, Kebebew E. Evaluation and management of pancreatic lesions in patients with von Hippel–Lindau disease. Nat Rev Clin Oncol 2016;13:537-49. [DOI: 10.1038/nrclinonc.2016.37] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Iliopoulos O. Diseases of Hereditary Renal Cell Cancers. Urol Clin North Am 2023;50:205-15. [PMID: 36948667 DOI: 10.1016/j.ucl.2023.01.010] [Reference Citation Analysis]
2 Halperin R, Tirosh A. Non-Interventional Management of Advanced Pancreatic Neuroendocrine Neoplasms in Patients with von Hippel-Lindau Disease. Cancers 2023;15:1739. [DOI: 10.3390/cancers15061739] [Reference Citation Analysis]
3 Halperin R, Arnon L, Eden-Friedman Y, Tirosh A. Unique Characteristics of Patients with Von Hippel-Lindau Disease Defined by Various Diagnostic Criteria. Cancers (Basel) 2023;15:1657. [PMID: 36980542 DOI: 10.3390/cancers15061657] [Reference Citation Analysis]
4 Wang H, Xiao N, Luo S, Li R, Zhao J, Ma Y, Zhao J, Qiang Y, Wang L, Lian J. Multi-scale dense selective network based on border modeling for lung nodule segmentation. Int J Comput Assist Radiol Surg 2023. [PMID: 36637749 DOI: 10.1007/s11548-022-02817-7] [Reference Citation Analysis]
5 Peraire Lores M, Domínguez J, Bravi CA, Mottaran A, Sarchi L, Paciotti M, Piro A, Nocera L, Balestrazzi E, Farinha R, Pauwaert K, Van Herwaarden M, Vinckier MH, De Backer P, De Groote R, D'Hondt F, De Naeyer G, Mottrie A. Robot-assisted sutureless partial nephrectomy for the treatment of fifteen bilateral renal masses in a patient with Von Hippel-Lindau syndrome: a case report from a high-volume robotic center. CEN Case Rep 2023. [PMID: 36611089 DOI: 10.1007/s13730-022-00770-7] [Reference Citation Analysis]
6 Persano I, Parlagreco E, La Salvia A, Audisio M, Volante M, Buttigliero C, Scagliotti GV, Brizzi MP. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review. Semin Oncol 2022;49:476-81. [PMID: 36759234 DOI: 10.1053/j.seminoncol.2023.01.007] [Reference Citation Analysis]
7 Fallah J, Brave MH, Weinstock C, Mehta GU, Bradford D, Gittleman H, Bloomquist EW, Charlab R, Hamed SS, Miller CP, Dorff SE, Chambers WA, Mixter BD, Dinin J, Pierce WF, Ricks TK, Tang S, Donoghue M, Pazdur R, Amiri-Kordestani L, Ibrahim A, Beaver JA. FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors. Clin Cancer Res 2022;28:4843-8. [PMID: 35727604 DOI: 10.1158/1078-0432.CCR-22-1054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
8 Mohindroo C, McAllister F, De Jesus-Acosta A. Genetics of Pancreatic Neuroendocrine Tumors. Hematol Oncol Clin North Am 2022:S0889-8588(22)00073-9. [PMID: 36154786 DOI: 10.1016/j.hoc.2022.07.005] [Reference Citation Analysis]
9 Larcher A, Belladelli F, Fallara G, Rowe I, Capitanio U, Marandino L, Raggi D, Capitanio JF, Bailo M, Lattanzio R, Barresi C, Calloni SF, Barbera M, Andreasi V, Guazzarotti G, Pipitone G, Carrera P, Necchi A, Mortini P, Bandello F, Falini A, Partelli S, Falconi M, De Cobelli F, Salonia A. Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians. Asian Journal of Urology 2022. [DOI: 10.1016/j.ajur.2022.08.002] [Reference Citation Analysis]
10 Wang H, Xiao N, Zhang J, Yang W, Ma Y, Suo Y, Zhao J, Qiang Y, Lian J, Yang Q. Static-Dynamic coordinated Transformer for Tumor Longitudinal Growth Prediction. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.105922] [Reference Citation Analysis]
11 Enny L, Garg S, Singh KR. Von Hippel Lindau Disease: A Review Article. Indian Journal of Endocrine Surgery and Research 2022;16:92-100. [DOI: 10.5005/jp-journals-10088-11175] [Reference Citation Analysis]
12 Kearney J, Johnson J, Kim HJ. Surgical Treatment of Pancreatic Islet Cell Tumors. Diagnosis and Management of Endocrine Disorders in Interventional Radiology 2022. [DOI: 10.1007/978-3-030-87189-5_15] [Reference Citation Analysis]
13 Frey S, Mirallié E, Le Bras M, Regenet N. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers (Basel) 2021;13:5954. [PMID: 34885063 DOI: 10.3390/cancers13235954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Laks S, van Leeuwaarde R, Patel D, Keutgen XM, Hammel P, Nilubol N, Links TP, Halfdanarson TR, Daniels AB, Tirosh A; Pancreatic Manifestations Recommendations Development Subcommittee of the VHL Alliance. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Cancer 2021. [PMID: 34735022 DOI: 10.1002/cncr.33978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Vaghaiwalla T, Keutgen XM. Surgical Management of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am 2020;29:243-52. [PMID: 32151358 DOI: 10.1016/j.soc.2019.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
16 Keutgen XM, Ornell KJ, Vogle A, Lakiza O, Williams J, Miller P, Mistretta KS, Setia N, Weichselbaum RR, Coburn JM. Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 2021. [PMID: 34091777 DOI: 10.1245/s10434-021-10245-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Oleinikov K, Grozinsky-glasberg S. Hereditary syndromes associated with neuroendocrine tumors. Current Opinion in Endocrine and Metabolic Research 2021;18:230-235. [DOI: 10.1016/j.coemr.2021.03.018] [Reference Citation Analysis]
18 Chevalier B, Dupuis H, Jannin A, Lemaitre M, Do Cao C, Cardot-Bauters C, Espiard S, Vantyghem MC. Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations. Front Endocrinol (Lausanne) 2021;12:678869. [PMID: 34025587 DOI: 10.3389/fendo.2021.678869] [Reference Citation Analysis]
19 Arnon L, Halperin R, Tirosh A. Impact of Pancreatic Neuroendocrine Tumor on Mortality in Patients With von Hippel-Lindau Disease. Endocr Pract 2021;27:1040-5. [PMID: 33737209 DOI: 10.1016/j.eprac.2021.03.005] [Reference Citation Analysis]
20 Greenberg SE, Maese LD, Maughan BL. VON HIPPEL–LINDAU SYNDROME. Cassidy and Allanson's Management of Genetic Syndromes 2021. [DOI: 10.1002/9781119432692.ch62] [Reference Citation Analysis]
21 Faggiano A, Feola T, Puliani G, Sesti F, Giannetta E. Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1. Neuroendocrine Neoplasia Management 2021. [DOI: 10.1007/978-3-030-72830-4_17] [Reference Citation Analysis]
22 Khalaf RT, Walker T, Mark J. Abundant Pancreatic Cysts in a Teenager Leading to a Diagnosis of Von Hippel-Lindau. J Pediatr Gastroenterol Nutr 2020;71:e129. [PMID: 32404765 DOI: 10.1097/MPG.0000000000002782] [Reference Citation Analysis]
23 McDonald JD, Gupta S, Shindorf ML, Copeland A, Good ML, Sadowski SM, Nilubol N. Pancreatic insufficiency following pancreatectomy: Does underlying tumor syndrome confer a greater risk? Am J Surg 2021;221:465-71. [PMID: 32943182 DOI: 10.1016/j.amjsurg.2020.08.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Tirosh A, Kebebew E. Genetic and epigenetic alterations in pancreatic neuroendocrine tumors. J Gastrointest Oncol 2020;11:567-77. [PMID: 32655936 DOI: 10.21037/jgo.2020.03.11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
25 Geurts JL. Inherited syndromes involving pancreatic neuroendocrine tumors. J Gastrointest Oncol 2020;11:559-66. [PMID: 32655935 DOI: 10.21037/jgo.2020.03.09] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
26 Alobuia W, Annes J, Kebebew E. Genetic testing in endocrine surgery: Opportunities for precision surgery. Surgery 2020;168:328-34. [PMID: 32376047 DOI: 10.1016/j.surg.2020.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 de Mestier L, Lepage C, Baudin E, Coriat R, Courbon F, Couvelard A, Do Cao C, Frampas E, Gaujoux S, Gincul R, Goudet P, Lombard-Bohas C, Poncet G, Smith D, Ruszniewski P, Lecomte T, Bouché O, Walter T, Cadiot G; Thésaurus National de Cancérologie Digestive (TNCD). Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis 2020;52:473-92. [PMID: 32234416 DOI: 10.1016/j.dld.2020.02.011] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 16.7] [Reference Citation Analysis]
28 Kim YH, Jung HL, Yang A, Kwak JH, Kim DS, Shim JY, Shim JW. A Case of Von Hippel-Lindau Disease Presented with Multiple Pancreatic Cysts and Medullary Hemangioblastoma. Clin Pediatr Hematol Oncol 2020;27:67-71. [DOI: 10.15264/cpho.2020.27.1.67] [Reference Citation Analysis]
29 Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, Minter RM, Lairmore TC, Tseng JF, Zeh HJ, Libutti SK, Singh G, Lee JE, Hope TA, Kim MK, Menda Y, Halfdanarson TR, Chan JA, Pommier RF. The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors. Pancreas 2020;49:1-33. [PMID: 31856076 DOI: 10.1097/MPA.0000000000001454] [Cited by in Crossref: 142] [Cited by in F6Publishing: 130] [Article Influence: 47.3] [Reference Citation Analysis]
30 Khorasani M, Law CHL, Myrehaug S, Singh S, Assal A, Hsieh E, Cukier M, Hallet J. Neuroendocrine Tumors (Gastroenteropancreatic). Surgical Oncology Manual 2020. [DOI: 10.1007/978-3-030-48363-0_18] [Reference Citation Analysis]
31 Datta A, Thomas V, Sebastian A, Thomas A, Chandy RG, Peedicayil A, Manoj Kumar R, Simon B. Von Hippel–Lindau Syndrome and Steroid Cell Tumour of the Ovary: A Rare Association. Indian J Gynecol Oncolog 2019;17:91. [DOI: 10.1007/s40944-019-0338-6] [Reference Citation Analysis]
32 Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Rev Anticancer Ther. 2019;19:1029-1050. [PMID: 31738624 DOI: 10.1080/14737140.2019.1693893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
33 Zhang L, Lu L, Wang X, Zhu RM, Bagheri M, Summers RM, Yao J. Spatio-Temporal Convolutional LSTMs for Tumor Growth Prediction by Learning 4D Longitudinal Patient Data. IEEE Trans Med Imaging 2020;39:1114-26. [PMID: 31562074 DOI: 10.1109/TMI.2019.2943841] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
34 Tirosh A, Sadowski SM, Linehan WM, Libutti SK, Patel D, Nilubol N, Kebebew E. Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease. JAMA Oncol 2018;4:124-6. [PMID: 29075773 DOI: 10.1001/jamaoncol.2017.3428] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
35 Minervini G, Quaglia F, Tabaro F, Tosatto SCE. Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors. PLoS Comput Biol 2019;15:e1006478. [PMID: 30943211 DOI: 10.1371/journal.pcbi.1006478] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
36 Tirosh A, Mukherjee S, Lack J, Gara SK, Wang S, Quezado MM, Keutgen XM, Wu X, Cam M, Kumar S, Patel D, Nilubol N, Tyagi MV, Kebebew E. Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors. Cancer 2019;125:1247-57. [PMID: 30620390 DOI: 10.1002/cncr.31930] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
37 Zhang L, Lu L, Summers RM, Kebebew E, Yao J. Convolutional Invasion and Expansion Networks for Tumor Growth Prediction. IEEE Trans Med Imaging. 2018;37:638-648. [PMID: 29408791 DOI: 10.1109/tmi.2017.2774044] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
38 Zhang L, Le L, Summers RM, Kebebew E, Yao J. Tumor Growth Prediction Using Convolutional Networks. Deep Learning and Convolutional Neural Networks for Medical Imaging and Clinical Informatics 2019. [DOI: 10.1007/978-3-030-13969-8_12] [Reference Citation Analysis]
39 Shell J, Tirosh A, Millo C, Sadowski SM, Assadipour Y, Green P, Patel D, Nilubol N, Kebebew E. The utility of 68Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors. Eur J Radiol 2019;112:130-5. [PMID: 30777201 DOI: 10.1016/j.ejrad.2018.11.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
40 Tirosh A, Journy N, Folio LR, Lee C, Leite C, Yao J, Kovacs W, Linehan WM, Malayeri A, Kebebew E, Berrington de González A. Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic Tumors. Radiology 2019;290:116-24. [PMID: 30299237 DOI: 10.1148/radiol.2018180687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 Krauss T, Ferrara AM, Links TP, Wellner U, Bancos I, Kvachenyuk A, Villar Gómez de Las Heras K, Yukina MY, Petrov R, Bullivant G, von Duecker L, Jadhav S, Ploeckinger U, Welin S, Schalin-Jäntti C, Gimm O, Pfeifer M, Ngeow J, Hasse-Lazar K, Sansó G, Qi X, Ugurlu MU, Diaz RE, Wohllk N, Peczkowska M, Aberle J, Lourenço DM Jr, Pereira MAA, Fragoso MCBV, Hoff AO, Almeida MQ, Violante AHD, Quidute ARP, Zhang Z, Recasens M, Díaz LR, Kunavisarut T, Wannachalee T, Sirinvaravong S, Jonasch E, Grozinsky-Glasberg S, Fraenkel M, Beltsevich D, Egorov VI, Bausch D, Schott M, Tiling N, Pennelli G, Zschiedrich S, Därr R, Ruf J, Denecke T, Link KH, Zovato S, von Dobschuetz E, Yaremchuk S, Amthauer H, Makay Ö, Patocs A, Walz MK, Huber TB, Seufert J, Hellman P, Kim RH, Kuchinskaya E, Schiavi F, Malinoc A, Reisch N, Jarzab B, Barontini M, Januszewicz A, Shah N, Young WF Jr, Opocher G, Eng C, Neumann HPH, Bausch B. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. Endocr Relat Cancer 2018;25:783-93. [PMID: 29748190 DOI: 10.1530/ERC-18-0100] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
42 Minervini G, Quaglia F, Tabaro F, Tosatto SC. Genotype-Phenotype Relations of the von Hippel-Lindau Tumor Suppressor Inferred from a Large-Scale Analysis of Disease Mutations and Interactors.. [DOI: 10.1101/405845] [Reference Citation Analysis]
43 Lee L, Ito T, Jensen RT. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther 2018;18:837-60. [PMID: 29973077 DOI: 10.1080/14737140.2018.1496822] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 8.4] [Reference Citation Analysis]
44 Katabathina VS, Rikhtehgar OY, Dasyam AK, Manickam R, Prasad SR. Genetics of Pancreatic Neoplasms and Role of Screening. Magn Reson Imaging Clin N Am. 2018;26:375-389. [PMID: 30376976 DOI: 10.1016/j.mric.2018.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
45 Ganeshan D, Menias CO, Pickhardt PJ, Sandrasegaran K, Lubner MG, Ramalingam P, Bhalla S. Tumors in von Hippel–Lindau Syndrome: From Head to Toe—Comprehensive State-of-the-Art Review. RadioGraphics 2018;38:849-66. [DOI: 10.1148/rg.2018170156] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
46 Yu R. Mahvash Disease: 10 Years After Discovery. Pancreas 2018;47:511-5. [PMID: 29702528 DOI: 10.1097/MPA.0000000000001044] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
47 Tirosh A, El Lakis M, Green P, Nockel P, Patel D, Nilubol N, Gara SK, Keutgen XM, Linehan WM, Kebebew E. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease. J Clin Endocrinol Metab 2018;103:1631-8. [PMID: 29294023 DOI: 10.1210/jc.2017-02434] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
48 Oudard S, Elaidi R, Brizard M, Le Rest C, Caillet V, Deveaux S, Benoit G, Corréas JM, Benoudiba F, David P, Gaudric A, Hammel P, Joly D, Timsit MO, Méjean A, Richard S. Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group. Oncotarget 2016;7:85306-17. [PMID: 27852035 DOI: 10.18632/oncotarget.13301] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
49 Thomaschewski M, Neeff H, Keck T, Neumann HPH, Strate T, von Dobschuetz E. Is there any role for minimally invasive surgery in NET? Rev Endocr Metab Disord 2017;18:443-57. [PMID: 29127554 DOI: 10.1007/s11154-017-9436-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
50 Yaghobi Joybari A, Azadeh P. Von Hippel-Lindau Disease With Multi-Organ Involvement: A Case Report and 8-Year Clinical Course With Follow-Up. Am J Case Rep 2017;18:1220-4. [PMID: 29146893 DOI: 10.12659/ajcr.907356] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
51 Keutgen XM, Kumar S, Gara SK, Boufraqech M, Agarwal S, Hruban RH, Nilubol N, Quezado M, Finney R, Cam M, Kebebew E. Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype. Cancer 2018;124:636-47. [PMID: 29149451 DOI: 10.1002/cncr.31057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
52 Leachman SA, Lucero OM, Sampson JE, Cassidy P, Bruno W, Queirolo P, Ghiorzo P. Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev 2017;36:77-90. [PMID: 28283772 DOI: 10.1007/s10555-017-9661-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 11.2] [Reference Citation Analysis]
53 OʼToole SM, Drake WM. Response to Somatostatin Analog Therapy in a Patient With von Hippel-Lindau Disease and Multiple Pancreatic Neuroendocrine Tumors. Pancreas 2017;46:e57. [PMID: 28697140 DOI: 10.1097/MPA.0000000000000865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
54 Shell J, Patel D, Powers A, Quezado M, Killian K, Meltzer P, Zhu J, Gaitanidis A, Karzai F, Neychev V, Green P, Kebebew E. Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report. J Endocr Soc 2017;1:1124-34. [PMID: 29264567 DOI: 10.1210/js.2017-00156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
55 Crespigio J, Berbel LCL, Dias MA, Berbel RF, Pereira SS, Pignatelli D, Mazzuco TL. Von Hippel-Lindau disease: a single gene, several hereditary tumors. J Endocrinol Invest 2018;41:21-31. [PMID: 28589383 DOI: 10.1007/s40618-017-0683-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
56 Dreijerink KM, van der Horst-schrivers AN, Links TP, Giles RH. Von Hippel-Lindau disease: a multidisciplinary neoplasia syndrome. International Journal of Endocrine Oncology 2017;4:5-8. [DOI: 10.2217/ije-2016-0021] [Reference Citation Analysis]
57 Libutti SK. Of mice and men(in) and what I have learned from both. Surgery 2017;161:1-11. [PMID: 27865595 DOI: 10.1016/j.surg.2016.10.004] [Reference Citation Analysis]